| Topoisomerases facilitate transcription of long genes linked to autism IF King, CN Yandava, AM Mabb, JS Hsiao, HS Huang, BL Pearson, ... Nature 501 (7465), 58-62, 2013 | 471 | 2013 |
| Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons HS Huang, JA Allen, AM Mabb, IF King, J Miriyala, B Taylor-Blake, ... Nature 481 (7380), 185-189, 2012 | 402 | 2012 |
| Division of labor in polycomb group repression SS Levine, IFG King, RE Kingston Trends in biochemical sciences 29 (9), 478-485, 2004 | 282 | 2004 |
| Oviposition preference for and positional avoidance of acetic acid provide a model for competing behavioral drives in Drosophila RM Joseph, AV Devineni, IFG King, U Heberlein Proceedings of the National Academy of Sciences 106 (27), 11352-11357, 2009 | 235 | 2009 |
| GABAergic neuron-specific loss of Ube3a causes Angelman syndrome-like EEG abnormalities and enhances seizure susceptibility MC Judson, ML Wallace, MS Sidorov, AC Burette, B Gu, GM van Woerden, ... Neuron 90 (1), 56-69, 2016 | 155 | 2016 |
| Native and recombinant polycomb group complexes establish a selective block to template accessibility to repress transcription in vitro IFG King, NJ Francis, RE Kingston Molecular and cellular biology, 2002 | 147 | 2002 |
| Propagation of silencing: recruitment and repression of naive chromatin in trans by Polycomb repressed chromatin M Lavigne, NJ Francis, IFG King, RE Kingston Molecular cell 13 (3), 415-425, 2004 | 122 | 2004 |
| Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics … P Horak, M Griffith, AM Danos, BA Pitel, S Madhavan, X Liu, C Chow, ... Genetics in Medicine 24 (5), 986-998, 2022 | 111 | 2022 |
| Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord SE Street, NJ Kramer, PL Walsh, B Taylor-Blake, MC Yadav, IF King, ... Journal of Neuroscience 33 (27), 11314-11322, 2013 | 97 | 2013 |
| Analysis of a polycomb group protein defines regions that link repressive activity on nucleosomal templates to in vivo function IFG King, RB Emmons, NJ Francis, B Wild, J Müller, RE Kingston, C Wu Molecular and cellular biology 25 (15), 6578-6591, 2005 | 95 | 2005 |
| Regulation of Polycomb group complexes by the sequence-specific DNA binding proteins Zeste and GAGA NM Mulholland, IFG King, RE Kingston Genes & development 17 (22), 2741-2746, 2003 | 94 | 2003 |
| Drosophila tao controls mushroom body development and ethanol-stimulated behavior through par-1 I King, LTY Tsai, R Pflanz, A Voigt, S Lee, H Jäckle, B Lu, U Heberlein Journal of Neuroscience 31 (3), 1139-1148, 2011 | 65 | 2011 |
| Topoisomerase 1 regulates gene expression in neurons through cleavage complex-dependent and-independent mechanisms AM Mabb, JM Simon, IF King, HM Lee, LK An, BD Philpot, MJ Zylka PLoS One 11 (5), e0156439, 2016 | 52 | 2016 |
| JNK pathway activation is controlled by Tao/TAOK3 to modulate ethanol sensitivity D Kapfhamer, I King, ME Zou, JP Lim, U Heberlein, FW Wolf PLoS one 7 (12), e50594, 2012 | 42 | 2012 |
| Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+ anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy AAN Rose, SM Armstrong, D Hogg, MO Butler, SD Saibil, DP Arteaga, ... Journal for immunotherapy of cancer 9 (1), 2021 | 41 | 2021 |
| Collaborative, multidisciplinary evaluation of cancer variants through virtual molecular tumor boards informs local clinical practices S Rao, B Pitel, AH Wagner, SM Boca, M McCoy, I King, S Gupta, BH Park, ... JCO clinical cancer informatics 4, 602-613, 2020 | 35 | 2020 |
| EGFR and FGFR pathways have distinct roles in Drosophila mushroom body development and ethanol-induced behavior IFG King, M Eddison, KR Kaun, U Heberlein PloS one 9 (1), e87714, 2014 | 21 | 2014 |
| Tao kinases as coordinators of actin and microtubule dynamics in developing neurons I King, U Heberlein Communicative & Integrative Biology 4 (5), 554-556, 2011 | 18 | 2011 |
| Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma A Madariaga, S Garg, N Tchrakian, NC Dhani, W Jimenez, S Welch, ... Nature Communications 14 (1), 1452, 2023 | 16 | 2023 |
| A clinical laboratory–developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia SWK Ng, T Murphy, I King, T Zhang, M Mah, Z Lu, N Stickle, N Ibrahimova, ... Blood Advances 6 (3), 1064-1073, 2022 | 15 | 2022 |
